Drugs / Troxacitabine
last change Oct 2007 re-read 3 minutes ago

Troxacitabine

Small molecule

Developed for
acute myeloid leukemia · leukemia · neoplasm
Investigated by
SGX Pharmaceuticals, Inc. · Shire

Trials 4

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/22 trials
Phase 1/2 NCT00104468 Apr 2003 → Jun 2007 acute myeloid leukemia SGX Pharmaceuticals, Inc. Terminated No outcome recorded
Phase 1/2 NCT00104286 Jan 2003 → Nov 2005 neoplasm SGX Pharmaceuticals, Inc. Terminated No outcome recorded
Phase 22 trials
Phase 2 NCT00129948 Jul 2005 → Oct 2007 acute myeloid leukemia SGX Pharmaceuticals, Inc. Terminated No outcome recorded
Phase 2 NCT00012259 Dec 2000 → Mar 2002 leukemia Shire Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Troxacitabine “An Open-Label, Single-Arm, Phase I Study of Troxatyl™ (Troxacitabine) Administered by Continuous Infusion in Subjects With an Advanced Solid Malignancy” NCT00104286 ↗
3

“Troxatyl™ (Troxacitabine) Administered by Continuous Infusion” NCT00104468 ↗

NCT00012259 ↗

NCT00129948 ↗

Known as (-)-ODDC ChEMBL registry synonym — accepted as the source's own label CHEMBL359164 ↗
Known as BCH-4556 ChEMBL registry synonym — accepted as the source's own label CHEMBL359164 ↗
Known as Lamivudine impurity i ChEMBL registry synonym — accepted as the source's own label CHEMBL359164 ↗
Known as Lamivudine impurity i rs ChEMBL registry synonym — accepted as the source's own label CHEMBL359164 ↗
Known as Troxacitabina ChEMBL registry synonym — accepted as the source's own label CHEMBL359164 ↗
Known as Troxatyl “Troxatyl™ (Troxacitabine) Administered by Continuous Infusion” NCT00104468 ↗
2

“Troxatyl™ (troxacitabine)” NCT00129948 ↗

NCT00104286 ↗

Modality Small molecule — CHEMBL359164 ↗
Route Intravenous “Patients receive troxacitabine IV over 30 minutes on days 1-5.” NCT00012259 ↗